A medical adhesive that combines strong adhesion and high flexibility! It quickly decomposes and disappears within the body!
Our company is engaged in the development of the medical adhesive LYDEX(R). LYDEX(R) is based on dextran, a polymer pharmaceutical ingredient with proven safety, and polylysine, a food additive. It consists of aldehyde-modified dextran and succinic anhydride-treated polylysine, which are obtained by simple modifications of each component. By mixing these two components in appropriate ratios, we can achieve a formulation that has high adhesive performance, exhibits sealing and hemostatic effects, and rapidly decomposes and disappears in the body after use. 【Features】 ■ Combines strong adhesion with high flexibility ■ Uses raw materials with no risk of infection, ensuring excellent safety ■ A medical adhesive that can be formulated in various forms and used in many fields ■ Research and development of application technologies is primarily advancing in five areas *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Applications】 ■ Medical hemostatic agents ■ Medical sealant materials ■ Medical adhesion prevention materials ■ Endoscopic wound covering materials ■ Drug release matrix (DDS), etc. *For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Kyoto University Institute for Advanced Medical Research. Focusing on the field of medical polymers (macromolecules), we are engaged in two promising growth businesses: the "BioDegmer" business and the new products business, as well as research and development aimed at providing innovative solutions in the medical field. Under the management philosophy of "contributing to the health of people around the world by working on the development of better biomaterial products and providing innovative solutions in the medical field," we support the improvement of technologies in the next generation of regenerative medicine and the healthy well-being of people in three areas.